These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19210277)

  • 21. Pharmacodynamics of unfractionated heparin during and after a hemodialysis session.
    Brunet P; Simon N; Opris A; Faure V; Lorec-Penet AM; Portugal H; Dussol B; Berland Y
    Am J Kidney Dis; 2008 May; 51(5):789-95. PubMed ID: 18436089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enoxaparin anticoagulation monitoring in the catheterization laboratory using a new bedside test.
    Silvain J; Beygui F; Ankri A; Bellemain-Appaix A; Pena A; Barthelemy O; Cayla G; Gallois V; Galier S; Costagliola D; Collet JP; Montalescot G
    J Am Coll Cardiol; 2010 Feb; 55(7):617-25. PubMed ID: 20170785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between on-line high-efficiency hemodiafiltration and conventional high-flux hemodialysis for polyclonal free light chain removal.
    Lamy T; Henri P; Lobbedez T; Comby E; Ryckelynck JP; Ficheux M
    Blood Purif; 2014; 37(2):93-8. PubMed ID: 24603634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dalteparin dosing in high-flux haemodialysis and haemodiafiltration.
    Sridharan S; Berdeprado J; Sivalingam M; Farrington K
    Nephron Clin Pract; 2012; 122(1-2):53-7. PubMed ID: 23548465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of single bolus anticoagulation with enoxaparin for chronic hemodialysis. Results of an open-label post-certification study.
    Klingel R; Schwarting A; Lotz J; Eckert M; Hohmann V; Hafner G
    Kidney Blood Press Res; 2004; 27(4):211-7. PubMed ID: 15273423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteocalcin and myoglobin removal in on-line hemodiafiltration versus low- and high-flux hemodialysis.
    Maduell F; Navarro V; Cruz MC; Torregrosa E; Garcia D; Simon V; Ferrero JA
    Am J Kidney Dis; 2002 Sep; 40(3):582-9. PubMed ID: 12200811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matching efficacy of online hemodiafiltration in simple hemodialysis mode.
    Krieter DH; Hunn E; Morgenroth A; Lemke HD; Wanner C
    Artif Organs; 2008 Dec; 32(12):903-9. PubMed ID: 19133017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cystatin C, beta2-microglobulin and C-reactive protein in hemodiafiltration and on-line endogenous liquid reinfusion and in low flux polysulphone bicarbonate conventional hemodialysis].
    Cristofano C; Vernaglione L; Perniola MA; Lo Barco C; Muscogiuri P; Chimienti S
    G Ital Nefrol; 2004; 21 Suppl 30():S197-200. PubMed ID: 15750984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the sensitivity of APTT reagents to the effects of enoxaparin, a low-molecular weight heparin.
    Ip BK; Thomson AR; Moriarty HT
    Pathology; 2001 Aug; 33(3):347-52. PubMed ID: 11523938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers and coagulation tests for assessing the biosimilarity of a generic low-molecular-weight heparin: results of a study in healthy subjects with enoxaparin.
    Kuczka K; Harder S; Picard-Willems B; Warnke A; Donath F; Bianchini P; Parma B; Blume H
    J Clin Pharmacol; 2008 Oct; 48(10):1189-96. PubMed ID: 18716314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bicarbonate balance in hemodiafiltration (HDF): a comparison between two infusion methods of on-line prepared solution].
    Sidoti A; Borracelli D; Biagioli M; Ghezzi PM
    G Ital Nefrol; 2004; 21 Suppl 30():S177-80. PubMed ID: 15750980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term on-line hemodiafiltration reduces predialysis beta-2-microglobulin levels in chronic hemodialysis patients.
    Lin CL; Yang CW; Chiang CC; Chang CT; Huang CC
    Blood Purif; 2001; 19(3):301-7. PubMed ID: 11244190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers.
    Sanderink GJ; Le Liboux A; Jariwala N; Harding N; Ozoux ML; Shukla U; Montay G; Boutouyrie B; Miro A
    Clin Pharmacol Ther; 2002 Sep; 72(3):308-18. PubMed ID: 12235452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of netilmicin in hypertonic hemodiafiltration and standard hemodialysis.
    Basile C; Di Maggio A; Curino E; Scatizzi A
    Clin Nephrol; 1985 Dec; 24(6):305-9. PubMed ID: 4075599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oxidative stress analysis in patients on hemodiafiltration on-line].
    Torregrosa E; Hernández Jaras J; Sastre J; Pons R; García Calvo H; Calvo Gordo C; Fenollosa MA; Rius A; Sánchez-Canel JJ; Pin M; Tamarit E; Rico I
    Nefrologia; 2007; 27(5):612-8. PubMed ID: 18045038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetics of enoxaparin do not correlate with its pharmacodynamic effect in patients receiving dialysis therapies.
    Brophy DF; Carr ME; Martin EJ; Venitz J; Gehr TW
    J Clin Pharmacol; 2006 Aug; 46(8):887-94. PubMed ID: 16855073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On-line hemodiafiltration in Southeast Asia: a three-year prospective study of a single center.
    Tiranathanagul K; Praditpornsilpa K; Katavetin P; Srisawat N; Townamchai N; Susantitaphong P; Tungsanga K; Eiam-Ong S
    Ther Apher Dial; 2009 Feb; 13(1):56-62. PubMed ID: 19379171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulation with fondaparinux for hemodiafiltration in patients with heparin-induced thrombocytopenia: dose-finding study and safety evaluation.
    Mahieu E; Claes K; Jacquemin M; Evenepoel P; Op De Beek K; Bogaert AM; Kuypers D; Verhamme P; Meijers B
    Artif Organs; 2013 May; 37(5):482-7. PubMed ID: 23461610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute hemodynamic response and uremic toxin removal in conventional and extended hemodialysis and hemodiafiltration: a randomized crossover study.
    Cornelis T; van der Sande FM; Eloot S; Cardinaels E; Bekers O; Damoiseaux J; Leunissen KM; Kooman JP
    Am J Kidney Dis; 2014 Aug; 64(2):247-56. PubMed ID: 24698199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot study.
    Hammerstingl C; Omran H; Tripp C; Poetzsch B
    Thromb Haemost; 2009 Feb; 101(2):325-32. PubMed ID: 19190817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.